Clinical Trials Directory

Trials / Completed

CompletedNCT00243256

Treatment of Obesity With Vitamin D (40.000 IE Per Week for 1 Year)

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
450 (estimated)
Sponsor
University of Tromso · Academic / Other
Sex
All
Age
21 Years – 70 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to evaluate if supplementation with vitamin D in doses of 20.000IU per week and 40.000 IU per week will result in weight loss in obese subjects as compared to placebo during 1 year.

Detailed description

We will include 450 obese subjects that will be devided in 3 groups: 40.000IU cholecalciferol per week, 20.000 IU cholecalciferol per week, and placebo. All subjects will be given 500 mg calcium per day. There will be visits every tird month. In addition to weight reduction, we will also evaluate the calcium metabolism (blood test and urin samples), insulin sensitivity, muscle strenght, blood pressure and depression.

Conditions

Interventions

TypeNameDescription
DRUGCholecalciferol

Timeline

Start date
2005-11-01
Completion
2007-12-01
First posted
2005-10-21
Last updated
2008-05-14

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT00243256. Inclusion in this directory is not an endorsement.

Treatment of Obesity With Vitamin D (40.000 IE Per Week for 1 Year) (NCT00243256) · Clinical Trials Directory